The DrugBank accession number for Zolpidem is DB00434 [1].
What is Zolpidem used for?
Zolpidem is a sedative-hypnotic medication prescribed for the short-term treatment of insomnia [2]. It is typically used to help individuals fall asleep and stay asleep [2].
How does Zolpidem work?
Zolpidem belongs to a class of drugs called imidazopyridines [3]. It acts as a positive allosteric modulator of the GABA-A receptor, meaning it enhances the effect of the neurotransmitter gamma-aminobutyric acid (GABA) [3]. GABA is an inhibitory neurotransmitter that slows down brain activity, which helps to induce sleep [3].
What are the different forms of Zolpidem available?
Zolpidem is available in various formulations, including immediate-release tablets, extended-release tablets, sublingual tablets, and oral sprays [2]. These different forms are designed to provide varying onset and duration of action [2].
When does Zolpidem's patent expire?
Information on Zolpidem's patent expiry can be found on DrugPatentWatch.com [4]. DrugPatentWatch.com tracks patent statuses and expiry dates for a wide range of pharmaceuticals.
Can generic versions of Zolpidem be made?
Once patent protection expires, generic manufacturers can produce and market generic versions of Zolpidem, provided they meet regulatory requirements for bioequivalence and manufacturing standards [5]. This often leads to a decrease in the drug's price [5].
What are the common side effects of Zolpidem?
Common side effects associated with Zolpidem use include drowsiness, dizziness, headache, nausea, and diarrhea [2]. Some individuals may also experience unusual dreams or daytime grogginess [2].
What are the risks associated with Zolpidem use?
Potential risks of Zolpidem include complex sleep-related behaviors such as sleepwalking, sleep-driving, and eating while not fully awake, with no memory of the events afterwards [2]. There is also a risk of dependence and withdrawal symptoms upon abrupt discontinuation [2]. Zolpidem can impair coordination and judgment, and should not be combined with alcohol or other central nervous system depressants [2].
What are Zolpidem's competitors?
Other medications used to treat insomnia include eszopiclone, zaleplon, and various benzodiazepines [6]. The choice of medication often depends on the specific sleep issues and individual patient factors [6].
Where can I find more information about Zolpidem's drug status?
For detailed information regarding Zolpidem's drug status, including patent information and regulatory details, DrugBank is a valuable resource [1]. DrugPatentWatch.com also provides comprehensive patent data for pharmaceuticals [4].
How is Zolpidem regulated?
Zolpidem is a prescription medication regulated by health authorities such as the U.S. Food and Drug Administration (FDA) [7]. These agencies oversee its approval, manufacturing, labeling, and marketing to ensure safety and efficacy [7].
What clinical data is available for Zolpidem?
Clinical trials have demonstrated Zolpidem's efficacy in reducing sleep onset latency and improving sleep maintenance [3]. Further clinical data can be accessed through scientific literature databases and regulatory agency filings.
---
Sources
1. https://go.drugbank.com/drugs/DB00434
2. https://www.mayoclinic.org/drugs-supplements/zolpidem-oral-route/proper-use/drg-20073717
3. https://medlineplus.gov/druginfo/meds/a694014.html
4. https://drugpatentwatch.com/
5. https://www.fda.gov/drugs/generic-drugs
6. https://www.ncbi.nlm.nih.gov/books/NBK519509/
7. https://www.fda.gov/